Analyst Ratings for Rain Therapeutics (RAIN)

RAIN Rating Summary

RAIN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RAIN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $11.00 (+609.7%) * Over Last 12-Mos
Rating Score: 1.8 / 10   Percentile Rank: 13%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/5/2023 Mizuho Graig Suvannavejh Downgrade Neutral
(Outperform)
1.00
(17.00)
1.11
(1.55)
39.64% Details
5/30/2023 Roth/MKM Kumaraguru Raja Downgrade Neutral
(Buy)
1.20
(2.00)
1.10
(1.55)
40.91% Details